Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

about

Immunohistochemical prognostic index for breast cancer in young women.Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas.

P2860

Q33919270-847B5D41-DFA8-4134-AC65-D765AAA4FA51 Q38342626-3FA07943-468A-4BA8-ACF1-0F4A0ACBBA04

P2860

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

Item

http://www.wikidata.org/entity/Q43011646

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

@en

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

@nl

type

Item

label

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

@en

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

@nl

prefLabel

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

@en

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

@nl

P1476

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

@en

P2093

T J Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

American Joint Committee on Cancer prognostic factors consensus conference.

Axillary staging of breast cancer and the sentinel node

Implications of pathologist concordance for breast cancer assessments in mammography screening from age 40 years.

Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC

Reliability of immunohistochemical demonstration of oestrogen receptors in routine practice: interlaboratory variance in the sensitivity of detection and evaluation of scoring systems.

Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma.

Pathology characteristics that optimize outcome prediction of a breast screening trial.

Problems in defining cutoff points of continuous prognostic factors: example of tumor thickness in primary cutaneous melanoma.

Histopathological workup of sentinel lymph nodes: how much is enough?

Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U. K. National Coordinating Group for Breast Screening Pathology.

P304

86-87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1136/JCP.55.2.86

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11497113

http://www.w3.org/2001/XMLSchema#string

P698

11864999

http://www.w3.org/2001/XMLSchema#string

P932

1769594

http://www.w3.org/2001/XMLSchema#string

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

about

P2860

P2860

Breast cancer prognostication in the 21st century and the Nottingham prognostic index.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932